United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$150Mraised across 1 round since 2025, from 2 sources
Bain CapitalLead
Wellington Management
Sofinnova Investments
Hatteras Venture Partners
Osage University Partners
Abingworth
Lightstone Ventures
Foundation Fighting BlindnessReported by Hatteras Venture Partners and 1 otherSEC filing: $90M sold, first sale Mar 2025
Missing a round, or an investor who was in one? Tell us.
Atsena Therapeutics's investors include Bain Capital, Bain Capital Life Sciences, Wellington Management, Sofinnova Investments and Hatteras Venture Partners, and 5 more on record. Bain Capital led its latest round.
Atsena Therapeutics has raised $150M across 1 round since 2025.
Atsena Therapeutics's most recent round was a Series C of $150M in Apr 2025, led by Bain Capital.
Its most recent round, $150M in Apr 2025, is also its largest on record.
Atsena Therapeutics's first round on record, in Apr 2025, was backed by Bain Capital, Bain Capital Life Sciences and Wellington Management and 7 others.
Atsena Therapeutics's latest named round is a Series C, in Apr 2025.
Atsena Therapeutics is based in the United States.
Bain Capital led the Series C in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
